
NBC Select independently determines what we cover and recommend. When you click on or buy through our links, we earn a commission. Learn more. Earlier this week, the FDA announced that 95 skin care products on the market containing benzoyl peroxide may be at risk for something called benzene contamination, which means they contain at least small amounts of the carcinogen commonly found in cigarette smoke and gasoline. Amongst the products listed? La Roche-Posay’s popular Effaclar Duo Dual Action Acne Treatment.
Main Idea: The FDA said some acne products may contain trace benzene, and La Roche-Posay voluntarily pulled its Effaclar Duo spot treatment from sale.
Key Points:
The FDA warning and La Roche-Posay recall may unsettle acne patients and force households to replace products they already bought.
The notice may help consumers choose safer acne treatments and reduce confusion by flagging products with possible benzene contamination.
Rate how each entity in this article affected the American people.
Brand/company that voluntarily recalled the acne treatment discussed in the story.
Central regulator whose announcement about possible benzene contamination drives the article.
Recommended acne treatment highlighted as a staff favorite and replacement option.
Brand whose micro-dart pimple patches are recommended as an alternative product.
Brand whose Drying Lotion is recommended as an alternative acne spot treatment.
Recommended acne spot treatment mentioned as an alternative.
NBC Select editorial director quoted for her experience with the recommended acne treatment.
Comments here are the same thread shown when this article appears in The Pulse.
No comments on this article yet.
Sign in to commentRecommended acne spot treatment mentioned as an alternative.